$ARIA ARIAD PHARMACEUTICALS INC Insider Trading Week 11/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARIAD PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARIAD PHARMACEUTICALS INC in week 11/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Option Exercise | M | 0.00 | 7,333 | 0 | 7,333 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Option Exercise | M | 0.00 | 6,500 | 0 | 13,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Sell | S | 7.89 | 3,667 | 28,930 | 82,379 | 86 K to 82.4 K (-4.26 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Buy | M | 0.00 | 7,333 | 0 | 86,046 | 78.7 K to 86 K (+9.32 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Payment of Exercise | F | 8.19 | 2,061 | 16,880 | 78,713 | 80.8 K to 78.7 K (-2.55 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Cantor Maria E | SVP, Corporate Affa ... | Buy | M | 0.00 | 6,500 | 0 | 80,774 | 74.3 K to 80.8 K (+8.75 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, GC and Chief I ... | Option Exercise | M | 0.00 | 4,000 | 0 | 4,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, GC and Chief I ... | Option Exercise | M | 0.00 | 4,750 | 0 | 9,500 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, GC and Chief I ... | Sell | S | 7.89 | 1,600 | 12,630 | 227,042 | 228.6 K to 227 K (-0.70 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, GC and Chief I ... | Buy | M | 0.00 | 4,000 | 0 | 228,642 | 224.6 K to 228.6 K (+1.78 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, GC and Chief I ... | Payment of Exercise | F | 8.19 | 1,506 | 12,334 | 224,642 | 226.1 K to 224.6 K (-0.67 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERSTEIN DAVID L | SVP, GC and Chief I ... | Buy | M | 0.00 | 4,750 | 0 | 226,148 | 221.4 K to 226.1 K (+2.15 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Option Exercise | M | 0.00 | 6,000 | 0 | 6,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Option Exercise | M | 0.00 | 6,500 | 0 | 13,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Sell | S | 7.89 | 2,400 | 18,941 | 99,196 | 101.6 K to 99.2 K (-2.36 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Buy | M | 0.00 | 6,000 | 0 | 101,596 | 95.6 K to 101.6 K (+6.28 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Payment of Exercise | F | 8.19 | 2,061 | 16,880 | 95,596 | 97.7 K to 95.6 K (-2.11 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Haluska Frank | SVP, Clinical R&D, ... | Buy | M | 0.00 | 6,500 | 0 | 97,657 | 91.2 K to 97.7 K (+7.13 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Option Exercise | M | 0.00 | 6,000 | 0 | 6,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Option Exercise | M | 0.00 | 8,000 | 0 | 16,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Sell | S | 7.89 | 2,400 | 18,936 | 144,463 | 146.9 K to 144.5 K (-1.63 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Buy | M | 0.00 | 6,000 | 0 | 146,863 | 140.9 K to 146.9 K (+4.26 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Payment of Exercise | F | 8.19 | 2,536 | 20,770 | 140,863 | 143.4 K to 140.9 K (-1.77 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Bollag Daniel M | Sr. VP, Reg. Affair ... | Buy | M | 0.00 | 8,000 | 0 | 143,399 | 135.4 K to 143.4 K (+5.91 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | M | 0.00 | 13,333 | 0 | 13,333 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Option Exercise | M | 0.00 | 10,834 | 0 | 21,666 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Sell | S | 7.89 | 6,667 | 52,583 | 394,377 | 401 K to 394.4 K (-1.66 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Buy | M | 0.00 | 13,333 | 0 | 401,044 | 387.7 K to 401 K (+3.44 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Payment of Exercise | F | 8.19 | 3,442 | 28,190 | 387,711 | 391.2 K to 387.7 K (-0.88 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | CLACKSON TIMOTHY P | President, R&D, CSO | Buy | M | 0.00 | 10,834 | 0 | 391,153 | 380.3 K to 391.2 K (+2.85 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 1,666 | 0 | 1,667 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Option Exercise | M | 0.00 | 8,000 | 0 | 16,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Payment of Exercise | F | 8.13 | 529 | 4,301 | 30,340 | 30.9 K to 30.3 K (-1.71 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 1,666 | 0 | 30,869 | 29.2 K to 30.9 K (+5.70 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Payment of Exercise | F | 8.19 | 2,618 | 21,441 | 29,203 | 31.8 K to 29.2 K (-8.23 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | Duvall Martin J | EVP, CCO | Buy | M | 0.00 | 8,000 | 0 | 31,821 | 23.8 K to 31.8 K (+33.58 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Option Exercise | M | 0.00 | 8,333 | 0 | 8,333 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Option Exercise | M | 0.00 | 10,834 | 0 | 21,666 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Payment of Exercise | F | 8.13 | 2,717 | 22,089 | 261,556 | 264.3 K to 261.6 K (-1.03 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Buy | M | 0.00 | 8,333 | 0 | 264,273 | 255.9 K to 264.3 K (+3.26 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Payment of Exercise | F | 8.19 | 3,435 | 28,133 | 255,940 | 259.4 K to 255.9 K (-1.32 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | FITZGERALD EDWARD M | Executive VP, CFO | Buy | M | 0.00 | 10,834 | 0 | 259,375 | 248.5 K to 259.4 K (+4.36 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Option Exercise | M | 0.00 | 34,000 | 0 | 34,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Option Exercise | M | 0.00 | 36,000 | 0 | 72,000 | |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Payment of Exercise | F | 8.13 | 11,084 | 90,113 | 1,097,964 | 1.1 M to 1.1 M (-1.00 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Buy | M | 0.00 | 34,000 | 0 | 1,109,048 | 1.1 M to 1.1 M (+3.16 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Payment of Exercise | F | 8.19 | 11,711 | 95,913 | 1,075,048 | 1.1 M to 1.1 M (-1.08 %) |
| Mar 21 2014 | ARIA | ARIAD PHARMACEUTIC ... | BERGER HARVEY J M D | Chairman & CEO | Buy | M | 0.00 | 36,000 | 0 | 1,086,759 | 1.1 M to 1.1 M (+3.43 %) |